Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Report of the 2006 RSPCA/UFAW Rodent Welfare Group meeting.

Reed B, Hawkins P, Latham N, Westwood K, van Driel K, Battram C, Golledge H, Farmer AM, Osborne N, Jennings M, Hubrecht R.

Lab Anim (NY). 2008 May;37(5):216-22. doi: 10.1038/laban0508-216.


Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation.

Stevenson CS, Docx C, Webster R, Battram C, Hynx D, Giddings J, Cooper PR, Chakravarty P, Rahman I, Marwick JA, Kirkham PA, Charman C, Richardson DL, Nirmala NR, Whittaker P, Butler K.

Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1183-93. Epub 2007 Aug 24.


Animal models of cough: literature review and presentation of a novel cigarette smoke-enhanced cough model in the guinea-pig.

Lewis CA, Ambrose C, Banner K, Battram C, Butler K, Giddings J, Mok J, Nasra J, Winny C, Poll C.

Pulm Pharmacol Ther. 2007;20(4):325-33. Epub 2006 Dec 13.


In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.

Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A.

J Pharmacol Exp Ther. 2006 May;317(2):762-70. Epub 2006 Jan 24.


Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma.

Belvisi MG, Bundschuh DS, Stoeck M, Wicks S, Underwood S, Battram CH, Haddad el-B, Webber SE, Foster ML.

J Pharmacol Exp Ther. 2005 Aug;314(2):568-74. Epub 2005 May 5.


Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways.

Birrell MA, Battram CH, Woodman P, McCluskie K, Belvisi MG.

Respir Res. 2003;4:3. Epub 2003 Mar 21.


Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation.

Birrell MA, McCluskie K, Haddad el-B, Battram CH, Webber SE, Foster ML, Yacoub MH, Belvisi MG.

J Pharmacol Exp Ther. 2003 Mar;304(3):1285-91.


Critical role for T cells in Sephadex-induced airway inflammation: pharmacological and immunological characterization and molecular biomarker identification.

Haddad el-B, Underwood SL, Dabrowski D, Birrell MA, McCluskie K, Battram CH, Pecoraro M, Foster ML, Belvisi MG.

J Immunol. 2002 Mar 15;168(6):3004-16.


Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.

Belvisi MG, Wicks SL, Battram CH, Bottoms SE, Redford JE, Woodman P, Brown TJ, Webber SE, Foster ML.

J Immunol. 2001 Feb 1;166(3):1975-82.


Anti-inflammatory properties of ebselen in a model of sephadex-induced lung inflammation.

Belvisi MG, Haddad EB, Battram C, Birrell M, Foster M, Webber S.

Eur Respir J. 2000 Mar;15(3):579-81.


Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.

Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE, et al.

Br J Pharmacol. 1994 Dec;113(4):1423-31.

Supplemental Content

Loading ...
Support Center